The COVID-19 pandemic has compelled regulatory agencies across the globe to offer some degree of flexibility in clinical trial processes to support ongoing research without compromising patient safety, data quality and data integrity.
EU Makes Only Limited Use Of Remote Clinical Trial Monitoring
While regulators worldwide are opening up to the possibility of remote verification of source data from clinical trial sites because of COVID-19 restrictions, this approach is finding less favor in the EU, mainly because of strict data protection rules.
